StonvexLoading…
StonvexStonvexStonvexCore line items from TEM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.27B | $693.40M | $531.82M | $320.67M |
Operating Income | $-252.87M | $-691.08M | $-196.08M | $-265.44M |
Net Income | $-245.03M | $-705.81M | $-214.12M | $-289.81M |
EPS (Diluted) | $-1.41 | $-6.23 | $-4.20 | $-5.30 |
Total Assets | $2.27B | $926.12M | $564.05M | Not available |
Total Liabilities | $1.78B | $869.78M | $840.67M | Not available |
Cash & Equivalents | $604.79M | $340.95M | $165.77M | $302.94M |
Free Cash Flow OCF − CapEx | $-239.14M | $-211.17M | $-248.95M | $-186.58M |
Shares Outstanding | 174.26K | 119.85K | 63.31K | 63.03K |